Loading…
AbbVie announced a $195 million investment to build a new active pharmaceutical ingredient (API) manufacturing facility at its North Chicago, Illinois plant. Construction will begin in fall 2025, with full operations expected in 2027.
“AbbVie today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S.”news.abbvie.com
Summarized from public sources; check the original articles before acting on it.